title: The clinical use of histamine-2 receptor antagonists.
abstract: Histamine-2 receptor antagonists have been available for fifteen years for the treatment of peptic ulcer disease and related disorders. While very safe, clinicians need to know correct dosing guidelines, drug interactions, and side effect profiles. Long-term therapy should be reserved for patients at high risk of recurrence.
authors.affiliation: University of Maryland Medical System.
authors.forename: R J
authors.initials: RJ
authors.lastname: Michocki
authors.forename: J P
authors.initials: JP
authors.lastname: Richardson
mesh_terms: D002927:Cimetidine / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D015738:Famotidine / Q000008:administration & dosage / Q000627:therapeutic use*; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D016567:Nizatidine / Q000008:administration & dosage / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000188:drug therapy*; D011899:Ranitidine / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D013997:Time Factors
chemical_list: D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine; D016567:Nizatidine